Literature DB >> 474543

Relative usefulness of three growth hormone stimulation screening tests.

B Fass, B M Lippe, S A Kaplan.   

Abstract

One hundred ninety-one children were tested by one of three screening procedures for growth hormone deficiency over a five-year period. Sleep screen yielded a 31.3% false-positive rate; levodopa administration alone yielded a 20.5% false-positive rate and levodopa in combination with propranolol yielded a 5.2% false-positive rate. These results support the view that the combined levodopa-propranolol hydrochloride screen test is superior to either the sleep or the levodopa screen tests in limiting the number of false-positive results and thus the need for further, more extensive testing.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 474543     DOI: 10.1001/archpedi.1979.02130090059010

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  9 in total

Review 1.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

2.  Investigation of suspected growth hormone deficiency. On behalf of the Health Services Human Growth Hormone Committee.

Authors:  R D Milner; E C Burns
Journal:  Arch Dis Child       Date:  1982-12       Impact factor: 3.791

3.  Stimulation of growth hormone secretion in children with X-linked hypophosphatemia.

Authors:  M G Seikaly; M Baum
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

4.  Premarin priming does not alter growth hormone release following exercise.

Authors:  R Lanes; F Lifshitz; C Sekaran; P Fort; B Recker
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

5.  Recombinant human growth hormone treatment of children following renal transplantation.

Authors:  R N Fine; O Yadin; P A Nelson; K Pyke-Grimm; M I Boechat; B H Lippe; B M Sherman; R B Ettenger; E Kamil
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 6.  Growth hormone deficiency in children.

Authors:  Erick J Richmond; Alan D Rogol
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

7.  Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1- to 3-year) outcome.

Authors:  R N Fine; K Pyke-Grimm; P A Nelson; M I Boechat; B M Lippe; O Yadin; E Kamil
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

8.  Clonidine is a better test for growth hormone deficiency than insulin hypoglycaemia.

Authors:  N C Fraser; J Seth; N S Brown
Journal:  Arch Dis Child       Date:  1983-05       Impact factor: 3.791

9.  Myalgia and Hematuria in Association with Clonidine and Arginine Administration for Growth Hormone Stimulation Tests.

Authors:  Meghan Glibbery; Adam Fleming; Rahul Chanchlani; Olufemi Abiodun Ajani; Norma Marchetti; Alexa Marr; M Constantine Samaan
Journal:  Case Rep Med       Date:  2020-05-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.